Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Meredith Buxton
Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-Spy 1 TRIAL—CALGB 150007/150012, ACRIN 6657
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Chemotherapy Response and Recurrence-Free Survival in Neoadjuvant Breast Cancer Depends on Biomarker Profiles: Results From the I-Spy 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Breast Cancer Research and Treatment
Cancer Research
Oncology
Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Pathologic Complete Response (pCR) to Neoadjuvant Chemoradiation (CRT) of uT2uN0 Rectal Cancer (RC) Treated by Local Excision (LE): Results of the ACOSOG Z6041 Trial.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases
HPB
Hepatology
Gastroenterology
MA25.10 Complete Response by PET-CT After Radical Treatment in Oligometastatic Non-Small Cell Lung Cancer Predicts Longer Survival
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Cyclin D3 Predicts Disease-Free Survival in Breast Cancer
Cancer Cell International
Cancer Research
Oncology
Genetics
Expression Profiling of Mitochondrial Voltage-Dependent Anion Channel-1 Associated Genes Predicts Recurrence-Free Survival in Human Carcinomas
PLoS ONE
Multidisciplinary
Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
Clinical Cancer Research
Cancer Research
Oncology
Expression of Nicotinamide Phosphoribosyltransferase-Influenced Genes Predicts Recurrence-Free Survival in Lung and Breast Cancers
Scientific Reports
Multidisciplinary
